CryoLife, Inc. (CRY)
(Delayed Data from NYSE)
$31.42 USD
-0.08 (-0.25%)
Updated May 3, 2019 04:02 PM ET
After-Market: $31.42 (%) 5:22 PM ET
NA Value
NA Growth NA Momentum NA VGMBrokerage Reports
0 items in cart
Artivion, Inc. [CRY]
Reports for Purchase
Showing records 1 - 20 ( 35 total )
Company: Artivion, Inc.
Industry: Medical - Instruments
Company: Artivion, Inc.
Industry: Medical - Instruments
Company: Artivion, Inc.
Industry: Medical - Instruments
Company: Artivion, Inc.
Industry: Medical - Instruments
Ascyrus Medical Acquisition Continues Trend of Bolton Products
Provider: Oppenheimer & Co. Inc.
Analyst: Research Department
Company: Artivion, Inc.
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Artivion, Inc.
Industry: Medical - Instruments
We are dropping coverage due to the realignment of the Med Tech research team.
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: Artivion, Inc.
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Artivion, Inc.
Industry: Medical - Instruments
Good Start - Consistent Outlook; Maintain Neutral
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Artivion, Inc.
Industry: Medical - Instruments
1Q13 MedTech Preview: ALGN ICUI TRIB CRY CPTS ATEC RTIX SLTM VOLC ATRC (Part 1)
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Artivion, Inc.
Industry: Medical - Instruments
Healthcare - 1Q 2013: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Artivion, Inc.
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Artivion, Inc.
Industry: Medical - Instruments
Good 4Q; Weaker FY13 EPS Outlook Due to R&D Investment; Maintain Neutral
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Artivion, Inc.
Industry: Medical - Instruments
Company: Artivion, Inc.
Industry: Medical - Instruments
Healthcare -4Q 2012: Quarterly Medical Technology Trading & Acquisition Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Artivion, Inc.
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Artivion, Inc.
Industry: Medical - Instruments
3Q - Raising PT on Beat and Raise; Guidance Still Conservative; Neutral
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Artivion, Inc.
Industry: Medical - Instruments
Company: Artivion, Inc.
Industry: Medical - Instruments
MORNING CALL SUMMARY
Provider: Roth Capital Partners, Inc.
Company: Artivion, Inc.
Industry: Medical - Instruments
Revs On-Track; Normalized EPS Guidance Down Modestly; Neutral
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M
Company: Artivion, Inc.
Industry: Medical - Instruments
Healthcare - 2Q 2012: Quarterly Medical Technology Trading & Acquisition Valuation Update
Provider: Roth Capital Partners, Inc.
Analyst: DOLAN M